Seroprevalence of Mycoplasma genitalium among Fertile and Infertile Women at Murtala Muhammad Specialist Hospital, Kano

Authors

  • Bakori, H. S. Department of Microbiology, Federal University, Dustinma, Katsina State, Nigeria
  • Kumurya, A. S. Department of Medical Laboratory Science, Bayero University, Kano, Nigeria
  • Abdulrazak Muhammad Idris Department of Medical Microbiology and Parasitology, Bayero University, Kano, Nigeria

DOI:

https://doi.org/10.47430/ujmr.2492.014

Keywords:

Mycoplasma genitalium, seroprevalence, fertility, infertility, IgG antibodies

Abstract

Study’s Excerpt

  • Seroprevalence of Mycoplasma genitalium IgG antibodies in fertile versus infertile women was investigated.
  • The findings revealed a counterintuitive higher seroprevalence among fertile women.
  • The results reveal no significant correlation between infection and various demographic or behavioral risk factors.

Full Abstract

Mycoplasma genitalium is an emerging sexually transmitted pathogen with potential implications for reproductive health. This study aimed to investigate and compare the seroprevalence of M. genitalium among fertile and infertile women to provide insights into its potential association with fertility outcomes. A cross-sectional study was conducted involving a total of 90 women, including 31 fertile and 59 infertile women. Serum samples were collected and tested for the presence of M. genitalium-IgG antibodies using ELISA detection techniques. Data on demographic characteristics, including age and education, were also collected. Prevalence rates of M. genitalium-IgG antibodies were calculated for both fertile and infertile groups, and a comparative analysis was performed. The seroprevalence of Mycoplasma genitalium-IgG antibodies was higher among fertile women (90.3%) compared to infertile women (84.7%). The largest age group was 25–29 years, representing 33.3% of participants, with 18 (20.0%) infertile and 12 (13.3%) fertile women. The majority of participants had secondary education. Risk factors, including sharing innerwear, type of toilet, awareness of sexually transmitted diseases, number of sexual partners, and family setting, showed no statistically significant associations with the presence of M. genitalium IgG (p > 0.05). The study revealed a notably higher seroprevalence of M. genitalium-IgG antibodies among fertile women compared to infertile women and recorded the non-significant association between M. genitalium infection and possible risk factors observed. 

Downloads

Download data is not yet available.

References

Ashraf, D.M, Ali, D. and khoshravi, A. (2013). Epidemiology of female infertility;A review of literature. Bioscience Biotechnology Research Asia 2013Dec 10(2):559-567.

https://doi.org/10.13005/bbra/1165

Chukwuka, C. P., Agbakoba, N. R., Emele, F. E., Oguejiofor, C.., Akujobi, C. N., Ezeagwuna, D. A. and Onwunzo M. (2013). Prevalence of Genital Mycoplasmas In the Vaginal Tracts of Adolescents in Nnewi, South-Eastern, Nigeria World Journal of Medical Sciences 9:(4): 248-253.

Deng, T., Liao, X. and Zhu, S. (2022). Recent Advances in Treatment of Recurrent Spontaneous Abortion. Obstetrical and gynecological survey, 77 (6): 355 – 66.

https://doi.org/10.1097/OGX.0000000000001033

Gnanadurai, R., and Fifer, H. (2020). Mycoplasma genitalium: a review. Microbiology, 166(1): 21 – 9. https://doi.org/10.1099/mic.0.000830

Idahl, A., Jurstrand, M., Olofsson, J. I., and Fredlund, H. (2015). Mycoplasma genitalium serum antibodies in infertile couples and fertile women: Table 1. Sexually Transmitted Infections, 91(8): 589 – 91. https://doi.org/10.1136/sextrans-2015-052011

Jensen, J. S., Cusini, M., Gomberg, M., Moi, H., Wilson, J., and Unemo, M. (2022). 2021 European guideline on the management of Mycoplasma genitalium infections. Journal of the European Academy of Dermatology and Venereology, 36(5): 641 – 50.

https://doi.org/10.1111/jdv.17972

Moridi, K., Hemmaty, M., Azimian, A., Fallah, M. H., Khaneghahi Abyaneh, H., and Ghazvini, K. (2020). Epidemiology of genital infections caused by Mycoplasma hominis, M. genitalium and Ureaplasma urealyticum in Iran; a systematic review and meta-analysis study (2000–2019). BMC Public Health, 20(1): 1020 – 33.

https://doi.org/10.1186/s12889-020-08962-5

National Bureau of Statistics (NBS) (2018).The latest population figures from National Bureau of Statistics you need to see; Business Insider by Pulse; Retrieved on 15th December 2022.

Nye, M. B., Harris, A. B., Pherson, A. J. and Cartwright, C. P. (2020). Prevalence of Mycoplasma genitalium infection in women with bacterial vaginosis. BMC Women's Health, 20: 62 – 7.

https://doi.org/10.1186/s12905-020-00926-6

Ojo, O. A., Nwafor-Ezeh, P. I., Rotimi, D. E., Iyobhebhe, M., Ogunlakin, A. D., and Ojo, A. B. (2023). Apoptosis, inflammation, and oxidative stress in infertility: A mini-review. Toxicology Reports 10 (2023): 448 – 62. https://doi.org/10.1016/j.toxrep.2023.04.006

Ravel, J., Moreno, I., and Simón, C. (2021). Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease. American journal of obstetrics and gynecology, 224(3): 251 – 57. https://doi.org/10.1016/j.ajog.2020.10.019

Rekha, S., Nooren, M., Kalyan, S., Mohan, M., Bharti, M., Monika, R., Anita, S., Kiran, S. and Vandana, N. (2019). Occurrence of Mycoplasma genitalium in the peritoneal fluid of fertile and infertile women with detailed analysis among infertile women. Microbial pathogenesis, 129, 183-186.

https://doi.org/10.1016/j.micpath.2019.02.006

Smolarczyk, K., Mlynarczyk-Bonikowska, B., Rudnicka, E., Szukiewicz, D., Meczekalski, B., Smolarczyk, R., and Pieta, W. (2021). The impact of selected bacterial sexually transmitted diseases on pregnancy and female fertility. International Journal of Molecular Sciences, 22(4): 2170.

https://doi.org/10.3390/ijms22042170

Stafford, I. A., Hummel, K., Dunn, J. J., Muldrew, K., Berra, A., Kravitz, E. S., Gogia, S., Martin, I. and Munson, E. (2021). Retrospective analysis of infection and antimicrobial resistance patterns of Mycoplasma genitalium among pregnant women in the southwestern USA. BMJ Open, 11(6): e050475.

https://doi.org/10.1136/bmjopen-2021-050475

Workowski, K. A., and Bachmann, L. H. (2022). Centers for Disease Control and Prevention’s sexually transmitted diseases infection guidelines. Clinical Infectious Diseases, 74(2): 89 – 94.

https://doi.org/10.1093/cid/ciab1055

Yu, J., Zhou, Y., Luo, H., Su, X., Gan, T., Wang, J., Ye, Z., Deng, Z. and He, J. (2023). Mycoplasma genitalium infection in the female reproductive system: Diseases and treatment. Frontiers in Microbiology, 14: 1098276. https://doi.org/10.3389/fmicb.2023.1098276

Zhang, Z., Zong, X., Bai, H., Fan, L., Li, T., and Liu, Z. (2023). Prevalence of Mycoplasma genitalium and Chlamydia trachomatis in Chinese female with lower reproductive tract infection: a multicenter epidemiological survey. BMC Infectious Diseases, 23(1): 1 – 11.

https://doi.org/10.1186/s12879-022-07975-2

Additional Files

Published

01-12-2024

How to Cite

Bakori, H. S., Kumurya, A. S., & Idris, A. M. (2024). Seroprevalence of Mycoplasma genitalium among Fertile and Infertile Women at Murtala Muhammad Specialist Hospital, Kano. UMYU Journal of Microbiology Research (UJMR), 9(2), 129–133. https://doi.org/10.47430/ujmr.2492.014

Most read articles by the same author(s)